Return On Assets of Regulus Therapeutics Inc. from 30 Jun 2013 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Regulus Therapeutics Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2013 to 31 Mar 2025.
  • Regulus Therapeutics Inc. Return On Assets for the quarter ending 31 Mar 2025 was -53%, a 3.9% increase year-over-year.
  • Regulus Therapeutics Inc. annual Return On Assets for 2024 was -47%, a 42% increase from 2023.
  • Regulus Therapeutics Inc. annual Return On Assets for 2023 was -81%, a 52% decline from 2022.
  • Regulus Therapeutics Inc. annual Return On Assets for 2022 was -53%, a 4.5% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Regulus Therapeutics Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 -53% +2% +3.9% 01 Jan 2025 31 Mar 2025
Q4 2024 -47% +34% +42% 01 Oct 2024 31 Dec 2024
Q3 2024 -49% +21% +30% 01 Jul 2024 30 Sep 2024
Q2 2024 -49% +14% +22% 01 Apr 2024 30 Jun 2024
Q1 2024 -55% +5% +8.3% 01 Jan 2024 31 Mar 2024
Q4 2023 -81% -28% -52% 01 Oct 2023 31 Dec 2023
Q3 2023 -70% -21% -43% 01 Jul 2023 30 Sep 2023
Q2 2023 -64% -11% -21% 01 Apr 2023 30 Jun 2023
Q1 2023 -60% -9% -18% 01 Jan 2023 31 Mar 2023
Q4 2022 -53% +2% +4.5% 01 Oct 2022 31 Dec 2022
Q3 2022 -49% +3% +6.1% 01 Jul 2022 30 Sep 2022
Q2 2022 -52% -14% -36% 01 Apr 2022 30 Jun 2022
Q1 2022 -51% -4% -9.4% 01 Jan 2022 31 Mar 2022
Q4 2021 -55% -7% -14% 01 Oct 2021 31 Dec 2021
Q3 2021 -52% +6% +10% 01 Jul 2021 30 Sep 2021
Q2 2021 -39% +34% +47% 01 Apr 2021 30 Jun 2021
Q1 2021 -47% +22% +31% 01 Jan 2021 31 Mar 2021
Q4 2020 -49% +20% +29% 01 Oct 2020 31 Dec 2020
Q3 2020 -58% +36% +39% 01 Jul 2020 30 Sep 2020
Q2 2020 -72% +28% +28% 01 Apr 2020 30 Jun 2020
Q1 2020 -69% +41% +37% 01 Jan 2020 31 Mar 2020
Q4 2019 -68% +44% +39% 01 Oct 2019 31 Dec 2019
Q3 2019 -94% +4% +3.8% 01 Jul 2019 30 Sep 2019
Q2 2019 -100% -14% -17% 01 Apr 2019 30 Jun 2019
Q1 2019 -109% -16% -18% 01 Jan 2019 31 Mar 2019
Q4 2018 -112% -19% -21% 01 Oct 2018 31 Dec 2018
Q3 2018 -98% -5% -5% 01 Jul 2018 30 Sep 2018
Q2 2018 -86% +4% +5% 01 Apr 2018 30 Jun 2018
Q1 2018 -93% -17% -23% 01 Jan 2018 31 Mar 2018
Q4 2017 -93% -24% -34% 01 Oct 2017 31 Dec 2017
Q3 2017 -93% -39% -73% 01 Jul 2017 30 Sep 2017
Q2 2017 -90% -44% -96% 01 Apr 2017 30 Jun 2017
Q1 2017 -76% -31% -70% 01 Jan 2017 31 Mar 2017
Q4 2016 -69% -32% -85% 01 Oct 2016 31 Dec 2016
Q3 2016 -54% -9% -19% 01 Jul 2016 30 Sep 2016
Q2 2016 -46% 0% -0.83% 01 Apr 2016 30 Jun 2016
Q1 2016 -44% -2% -5.3% 01 Jan 2016 31 Mar 2016
Q4 2015 -37% +7% +16% 01 Oct 2015 31 Dec 2015
Q3 2015 -45% -14% -43% 01 Jul 2015 30 Sep 2015
Q2 2015 -46% -22% -95% 01 Apr 2015 30 Jun 2015
Q1 2015 -42% -22% -105% 01 Jan 2015 31 Mar 2015
Q4 2014 -44% -27% -162% 01 Oct 2014 31 Dec 2014
Q3 2014 -31% -9% -41% 01 Jul 2014 30 Sep 2014
Q2 2014 -23% +9% +28% 01 Apr 2014 30 Jun 2014
Q1 2014 -21% 01 Jan 2014 31 Mar 2014
Q4 2013 -17% 01 Oct 2013 31 Dec 2013
Q3 2013 -22% 01 Jul 2013 30 Sep 2013
Q2 2013 -33% 01 Apr 2013 30 Jun 2013

Regulus Therapeutics Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -47% +34% +42% 01 Jan 2024 31 Dec 2024
2023 -81% -28% -52% 01 Jan 2023 31 Dec 2023
2022 -53% +2% +4.5% 01 Jan 2022 31 Dec 2022
2021 -55% -7% -14% 01 Jan 2021 31 Dec 2021
2020 -49% +20% +29% 01 Jan 2020 31 Dec 2020
2019 -68% +44% +39% 01 Jan 2019 31 Dec 2019
2018 -112% -19% -21% 01 Jan 2018 31 Dec 2018
2017 -93% -24% -34% 01 Jan 2017 31 Dec 2017
2016 -69% -32% -85% 01 Jan 2016 31 Dec 2016
2015 -37% +7% +16% 01 Jan 2015 31 Dec 2015
2014 -44% -27% -162% 01 Jan 2014 31 Dec 2014
2013 -17% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.